Search

Your search keyword '"Archambeaud, F."' showing total 136 results
Start Over Author "Archambeaud, F."
136 results on '"Archambeaud, F."'

2. Indications thérapeutiques et effets métaboliques de la métréleptine chez les patients atteints de lipodystrophie : données de vie réelle du registre français

Author

Mosbah, H., primary, Vantyghem, M.C., additional, Guilleux, A., additional, Andreelli, F., additional, Archambeaud, F., additional, Bismuth, E., additional, Briet, C., additional, Cartigny, M., additional, DaguenelNguyen, A., additional, Donadille, B., additional, Fichet, M., additional, Gautier, J.F., additional, Janmaat, S., additional, Jéru, I., additional, Legagneur, C., additional, Maitre, J., additional, Mongeois, E., additional, Nobécourt, E., additional, Poitou, C., additional, Renard, E., additional, Reznik, Y., additional, Spiteri, A., additional, Travert, F., additional, Vergès, B., additional, Zammouri, J., additional, Vigouroux, C., additional, and Vatier, C., additional

Published
2021
Full Text
View/download PDF

3. Conséquences des variants pathogènes de PPARG responsables de lipodystrophie familiale partielle de type 3 (FPLD3) sur le déroulement de la grossesse et le développement in utero

Author

Gosseaume, C., primary, Fournier, T., additional, Jeru, I., additional, Missotte, I., additional, Pienkowski, C., additional, Guerci, B., additional, Nobecourt, E., additional, Debussche, X., additional, Archambeaud, F., additional, Thissen, J.P., additional, Lascols, O., additional, Degrelle, S., additional, Vigouroux, C., additional, and Vatier, C., additional

Published
2020
Full Text
View/download PDF

4. Comparison of Seven Serum Thyroglobulin Assays in the Follow-Up of Papillary and Follicular Thyroid Cancer Patients

Author

Schlumberger, M, Hitzel, A, Toubert, M E., Corone, C, Troalen, F, Schlageter, M H., Claustrat, F, Koscielny, S, Taieb, D, Toubeau, M, Bonichon, F, Borson-Chazot, F, Leenhardt, L, Schvartz, C, Dejax, C, Brenot-Rossi, I, Torlontano, M, Tenenbaum, F, Bardet, S, Bussière, F, Girard, J J., Morel, O, Schneegans, O, Schlienger, J L., Prost, A, So, D, Archambeaud, F, Ricard, M, and Benhamou, E

Published
2007

5. Clinical Characterization of Familial Isolated Pituitary Adenomas

Author

Daly, A F., Jaffrain-Rea, M -L., Ciccarelli, A, Valdes-Socin, H, Rohmer, V, Tamburrano, G, Borson-Chazot, C, Estour, B, Ciccarelli, E, Brue, T, Ferolla, P, Emy, P, Colao, A, De Menis, E, Lecomte, P, Penfornis, F, Delemer, B, Bertherat, J, Wémeau, J L., De Herder, W, Archambeaud, F, Stevenaert, A, Calender, A, Murat, A, Cavagnini, F, and Beckers, A

Published
2006

6. French Endocrine Society Guidance on endocrine side effects of immunotherapy

Author

Castinetti, F, primary, Albarel, F, additional, Archambeaud, F, additional, Bertherat, J, additional, Bouillet, B, additional, Buffier, P, additional, Briet, C, additional, Cariou, B, additional, Caron, Ph, additional, Chabre, O, additional, Chanson, Ph, additional, Cortet, C, additional, Do Cao, C, additional, Drui, D, additional, Haissaguerre, M, additional, Hescot, S, additional, Illouz, F, additional, Kuhn, E, additional, Lahlou, N, additional, Merlen, E, additional, Raverot, V, additional, Smati, S, additional, Verges, B, additional, and Borson-Chazot, F, additional

Published
2019
Full Text
View/download PDF

9. ACRONIS, étude observationnelle européenne chez les patients acromégales non contrôlés, traités par pasiréotide à libération prolongée (PAS-LP) : analyse intermédiaire

Author

Tabarin, A., primary, Chabre, O., additional, Desailloud, R., additional, Chanson, P., additional, Caron, P., additional, Raingeard, I., additional, Raverot, G., additional, Verges, B., additional, Archambeaud, F., additional, Buccino-Boda, M., additional, Brue, T., additional, Cailleux, A., additional, Schöfl, C., additional, Enderle, G., additional, Mesenka, D., additional, Nora, T., additional, Ladarre, N., additional, and Delemer, B., additional

Published
2018
Full Text
View/download PDF

10. Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France

Author

Young, Jacques, primary, Bertherat, Jérôme, additional, Vantyghem, Marie Christine, additional, Chabre, Olivier, additional, Senoussi, Salima, additional, Chadarevian, Rita, additional, Castinetti, Frédéric, additional, _, _, additional, Abeillon, J, additional, Ajzenberg, C, additional, Andrieu, J-M, additional, Arbey, A-S, additional, Archambeaud, F, additional, Arnault, G, additional, Bacchetta, J, additional, Baechler-Sadoul, E, additional, Bakiri, F, additional, Batisse-Lignier, M, additional, Baudry, C, additional, Benamo, E, additional, Bennet, A, additional, Berdelou, A, additional, Bertherat, J, additional, Boehna, A, additional, Borson-Chazot, F, additional, Bourcigaux, N, additional, Bourquard, C, additional, Bouys, L, additional, Bremont-Weill, C, additional, Bricaire, L, additional, Brue, T, additional, Buliga, D, additional, Cabaret, P, additional, Caron, P, additional, Cerro-Martinez, M, additional, Chambre, C, additional, Chardonnet, M, additional, Chatelin, J, additional, Clavel, C, additional, Coffin, C, additional, Cohen, R, additional, Collet-Gaudillat, C, additional, Cortet, C, additional, Coulon, A-L, additional, De Boisvilliers, F, additional, Decker-Bellaton, A, additional, Delemer, B, additional, De Menthon, M, additional, Degros, V, additional, Deneuville, T, additional, Desailloud, R, additional, Di Pietro, G, additional, Do Cao, C, additional, Donadille, B, additional, Dolz, M, additional, Dubray-Longeras, P, additional, Dutertre, E, additional, Du Rostu, H, additional, El Farkh, J, additional, Faure, G, additional, Finichel, P, additional, Gaits, N, additional, Galland, F, additional, Genc, S, additional, Ghanassia, E, additional, Girard, J-J, additional, Gravis, G, additional, Groza, L, additional, Grunenberger, F, additional, Guiheneuf, C, additional, Guignat, L, additional, Guigui, M, additional, Guilhem, A, additional, Joubert, M, additional, Jublanc, C, additional, Kamenicky, P, additional, Kerlan, V, additional, Khalfallah, Y, additional, Lambrey, G, additional, Landau, E, additional, Lautridou, C, additional, Lefebvre, H, additional, Le Bras, M, additional, Le Guillou, A-C, additional, Le Pommelet, C, additional, Léonard, F, additional, Lin, L, additional, Luca, F, additional, Lunogo, C, additional, Maisin, A, additional, Maiza, J-C, additional, Marty, M, additional, Meliani, P, additional, Menon, S, additional, Mestre, B, additional, Mignot, B, additional, Millot, S, additional, Morange, I, additional, Moret, M, additional, Morlet-Barla, N, additional, Narbonne, H, additional, Néraud, B, additional, Néri, N, additional, Niccoli, P, additional, Nunes, M L, additional, Oudard, S, additional, Papadopoulou, S, additional, Petit, J-M, additional, Petit-Aubert, G, additional, Perrin, A, additional, Philippon, M, additional, Pillegrand, C, additional, Potton, L, additional, Raverot, G, additional, Rodes, M L, additional, Reznik, Y, additional, Sadoul, J L, additional, Salenave, S, additional, Saraval-Gross, M, additional, Sarfati, J, additional, Savel, J, additional, Schletzer, M A, additional, Schneebeli, S, additional, Schillo, F, additional, Smagala, A, additional, Sonnet, E, additional, Teissier, R, additional, Tessier, M P, additional, Trulli, F, additional, Vackrine, C, additional, Vezzosi, D, additional, Viard, A, additional, Villeneuve, A, additional, Weryha, G, additional, and Zalzali, M, additional

Published
2018
Full Text
View/download PDF

11. Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study

Author

Bauduceau, B, Blicklé, J-F, Bourdel-Marchasson, I, Constans, T, Doucet, J, Fagot-Campagna, A, Kaloustian, E, Lassmann-Vague, V, Lecomte, P, Tessier, D, Verny, C, Vischer, U, Affres, H, Alix, M, Archambeaud, F, Barrou, Z, Beau, P, Beltran, S, Benoit, C, Beressi, J-P, Bernachon, F, Berne, C, Berrut, G, Blaimont, A, Blickle, J-F, Boda-Buccino, M, Bohatier, J, Böhme, P, Bordier, L, Bouchou, K, Bouillet, B, Bouilloud, F, Bouix, R, Boulanger, E, Bourgon, C, Bourrinet, E, Brocker, P, Bruckert, I, Capet, C, Carette, C, Cariou, B, Carreau, A, Vaurie, C Chaillou, Chamouni, S, Ciangura, C, Collet-Gaudillat, C, Combes-Moukhovsky, M-E, Cordonnier, M, Cuperlier, A, Dambre, D, D'Avigneau, J, De Botton, P, Degros, V, Delamarre-Damier, F, Denat, S, Desbiez, F, Deumier, B, Dorey, F, Dresco, E, Drutel, A, De Saint Germain, E Du Rosel, Dubois-Laforgue, D, Duly-Bouhanick, B, Dupuy, O, Dusselier, L, Faucher-Kareche, S, Fendri, S, Fontaine, P, Galinat, S, Gentric, A, Gin, H, Glaise, F, Godeau, T, Gonzales, B, Got, I, Guerci, B, Guillausseau, P-J, Hadjadj, S, Hadjali, Y, Halbron, M, Halimi, S, Halter, C, Hanaire, H, Hardy, V, Hartemann-Heurtier, A, Haulot, J-P, Hequet, F, Issa-Sayegh, M, Jan, P, Jeandidier, N, Joseph-Henri, H, Julier, I, Kerlan, V, Kharitonnoff, T, Ladsous, M, Lahaxe, L, Lamaraud, M-P, Lassenne, E, Lecerf, J-M, Leroux, I, Lesven, S, Levy, M, Lopez, S, Makiza, F, Manckoundia, P, Pomeau, C Marquis, Mayaudon, H, Micheli, S, Mira, R, Monnier, F, Mosnier-Pudar, H, Neri, N, Normand, I, Paccalin, M, Pagu, C, Paris, D, Penfornis, A, Perie, J-L, Petit, J-M, Petit-Aubert, G, Pichot-Duclos, B, Pivois, L, Popelier, M, Poulingue, G, Priner, M, Quipourt, V, Rasamisoa, M, Richard, J-L, Rigalleau, V, Roudat, N, Sanz, C, Serot, J-M, Sifi, D, Sirvain, S, Slimani, A, Sonnet, E, Sosset, C, Soualah, A, Stroea, A, Tauveron, I, Timsit, J, Tschudnowsky, M, Vambergue, A, Verier-Mine, O, Virally, M, Bordier, L., Buysschaert, M., Bauduceau, B., Doucet, J., Verny, C., Lassmann Vague, V., and Le Floch, J.P.

Published
2015
Full Text
View/download PDF

12. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

Author

James, Wp, Caterson, Id, Coutinho, W, Finer, N, VAN GAAL LF, Maggioni, Ap, TORP-PEDERSEN, C, Sharma, Am, Shepherd, Gm, Rode, Ra, Renz, Cl, Van Gaal LF, Torp-Pedersen, C, Pepine, C, Pocock, S, Drexler, H, Swedberg, K, Sleight, P, Armstrong, P, Kerr, D, Dagenais, G, Brophy, J, Avezum, A, Bogaty, P, Fabbri, G, Galli, M, Hildebrandt, P, Mann, J, Ostergren, J, Sherman, D, Zannad, F, Colquhoun, D, Hollanders, G, e Forti A, Costa, Cifkova, R, Toubro, S, Ziegler, O, Scherbaum, Wa, Jordan, J, Halmy, L, Ferrannini, E, Santini, F, Gonzalez, C, Narkiewicz, K, Hancu, N, Payer, J, Pascual, J, Wilding, J, Campbell, L, Carey, D, Gerstman, M, Karrasch, J, Lefkovits, J, Marks, J, Marks, S, Moses, R, Phillips, P, Proietto, J, Roberts, D, Roberts-Thomson, P, Shaw, J, Simpson, R, Singh, B, Singleton Jeffries, W, Stuckey, B, Boland, J, Brohet, C, Coucke, F, Dendale, P, Jouret, G, Kolanowski, J, Kutnowski, M, Martens, F, Muls, E, Peiffer, F, Penninckx, H, Scheen, A, Schoors, D, Vaerenberg, M, Van Cleemput, J, Van Crombrugge, P, Van Kuyk, M, Verhaegen, A, Wollaert, B, de Albuquerque DC, Appolinario, J, de Godoy Matos AF, Gross, Jl, Halpern, A, Kerr Saraiva JF, Milagres, R, Repetto, G, Suplicy, Hl, Zanella, Mt, Bednarova, J, Cepelak, V, Cerny, P, Hainer, V, Havranek, P, Homza, M, Jansa, P, Karlicek, M, Kolesar, J, Kotik, I, Kucera, D, Kuchar, J, Kunc, M, Kvapil, M, Linhart, A, Machova, V, Matuska, J, Oral, I, Pavlas, J, Pesatova, S, Povolny, J, Semrad, B, Smetana, K, Soucek, M, Svacina, S, Tesinsky, P, Urbanek, R, Wasserburger, B, Zachoval, R, Zahumensky, E, Zidkova, E, Astrup, A, Dominguez, H, Faber, J, Hilderbrant, P, Kober, L, Perrild, H, Richelsen, B, Sogaard, P, Svendsen, Ol, Urhammer, S, Archambeaud, F, Basdevant, A, Borys, Jm, Bringer, J, Brunetiere, C, Charpentier, G, Cocaul-André, M, Dabadie, H, Dubreuil, A, Estour, B, Gautier, Jf, Gibault, T, Halimi, S, Hespel, Jp, Issa Sayegh, M, Krempf, M, Laville, M, Lecerf, Jm, Louvet, Jp, Penfornis, A, Ritz, P, Schlienger, Jl, Schmitt, B, Valensi, P, Baar, M, Beermann, J, Bock, M, Boenner, G, Dammann, Hg, Diehm, C, Ditschuneit, H, Gadow, J, Gehlhar, S, Gessner, S, Guthersohn, A, Hamann, A, Hanefeld, M, Hasenfuss, G, Herzner, A, Heun, Kc, Heufelder, Ae, Hohensee, H, Jacob, S, Krings, P, Krätzig, B, Krosse, B, Lehmann, Rt, Mindt-Prüfert, S, Maisch, B, Pfeiffer, Af, Richard, F, Rose, B, Schmidt, E, Scholze, J, Schreckenberg, A, Stuebler, P, Walter, J, Wirth, A, Wunderlich, J, Abraham, G, Altorjay, A, Augusztin, G, Csaszar, A, Czuriga, I, Dinnyes, J, Gero, L, Gyimesi, A, Janosi, A, Kovacs, I, Liziczai, I, Majtenyi, A, Medvegy, M, Nadhazi, Z, Pados, G, Polak, G, Ronaszeki, A, Sido, Z, Simon, K, Anzà, C, Bevilacqua, M, Bosello, O, Chiariello, M, Cordera, R, Ferrari, E, Frittitta, L, Giorgino, R, Liuzzi, A, Malinverni, C, Di Mario, U, Melchionda, N, Occhi, G, Perticone, F, Pinchera, A, Pinelli, G, Rovera, G, Santeusanio, F, Urbinati, S, Alpizar-Salazar, M, Carrillo-Ortega, E, Fanghanel Salmon, G, Laviada-Molina, Ha, Madero, Ma, Rodriguez, G, Saldate, C, Sanchez-Castillo, Cp, Violante, Rm, Wacher, N, Zayas-Jaime, Fj, Zuniga-Guajardo, S, Adamiec, R, Banasiak, W, Chrusciel, P, Derlaga, B, Gebala, A, Gessek, J, Janik, K, Janion, M, Kalina, Z, Kozlowski, A, Kusnierz, B, Majcher, Z, Miekus, P, Niegowska, J, Okopien, B, Ostrowska, L, Pasowicz, M, Piepiorka, M, Pluta, W, Polaszewska-Muszynska, M, Ponikowski, P, Pupek-Musialik, D, Sawicki, A, Sobocik, H, Stankiewicz, A, Szpajer, M, Trojnar, R, Tykarski, A, Wrabec, K, Wyrzkowski, B, Zahorska-Markiewicz, B, Zalewski, M, Carrageta, M, Mendes Pedro MM, Parente Martins LM, dos Santos, L, Babes, A, Creteanu, G, Dan, Ga, Dragulescu, Si, Graur, M, Tirgoviste, Ci, Morosanu, M, Mota, M, Paveliu, Fs, Radoi, M, Ranetti, A, Totoian, I, Andre, I, Bugan, V, Cencarik, J, Csala, L, Farsky, S, Gonsorcik, J, Kamensky, G, Kmec, J, Krahulec, B, Kurian, R, Macek, V, Majercak, I, Micko, K, Mokan, M, Riecansky, I, Sojka, G, Uhliar, R, Urgeova, L, Vancik, J, Baro, Fm, Barrios Merino, A, Borras, Jl, Caixas, A, Cuatrecasas Cambra, G, Dominguez Escribano JR, Duran Garcia, S, Escobar-Jimenez, L, Esteva de Antonio, I, Formiguera Sala, X, Garcia-Luna, Pp, Garcia Robles, R, Gonzalez Albarran, O, Hernandez-Mijares, A, Martin Hidalgo, A, Masmiquel Comas, L, Morales Perez, F, Moreno Esteban, B, Pascual Izuel JM, Redon Mas, J, Ricart, W, Rubio, Ma, Ruilope, Lm, Salas-Salvado, J, Terroba Larumbe, M, Tinahones, F, de la Torre Casares ML, Vidal Cortada, J, Zuniga-Perez Lemaur, M, Abdulhakim, Ee, Adler, A, Barnett, Ah, Bodmer, C, Campbell, Iw, Chowdhury, T, Cleland, J, Cook, Rc, Dinneen, S, Donnachie, H, Haslam, Dw, Hillis, Gs, Horne, M, Howarth, Dj, Hughes, E, Jackson, S, Jones, Sc, Jones, Th, Kumar, S, Lean, M, Maroni, J, Mcinnes, G, Middleton, A, Morris, A, Newcombe, G, O'Kane, Kp, Pavel, Ic, Pawa, R, Perry, C, Pitts, C, Raja, A, Reckless, J, Robinson, J, Sarmiento, R, Soo, Sc, Taylor, S, Thomas, Ho, Thomson, Ma, and Wilkins, M.

Subjects
Male, medicine.medical_specialty, Myocardial Infarction, Blood Pressure, Kaplan-Meier Estimate, Type 2 diabetes, Klinikai orvostudományok, Placebo, law.invention, Double-Blind Method, Randomized controlled trial, Weight loss, law, Internal medicine, Appetite Depressants, medicine, Humans, Obesity, Myocardial infarction, Stroke, Aged, business.industry, Hazard ratio, Orvostudományok, General Medicine, Middle Aged, Overweight, medicine.disease, Surgery, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiology, Female, Human medicine, medicine.symptom, business, Cyclobutanes, Sibutramine, medicine.drug
Abstract

Background The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established. Methods We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting cardiovascular disease, type 2 diabetes mellitus, or both to assess the cardiovascular consequences of weight management with and without sibutramine in subjects at high risk for cardiovascular events. All the subjects received sibutramine in addition to participating in a weight-management program during a 6-week, single-blind, lead-in period, after which 9804 subjects underwent random assignment in a double-blind fashion to sibutramine (4906 subjects) or placebo (4898 subjects). The primary end point was the time from randomization to the first occurrence of a primary outcome event (nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, or cardiovascular death). Results The mean duration of treatment was 3.4 years. The mean weight loss during the lead-in period was 2.6 kg; after randomization, the subjects in the sibutramine group achieved and maintained further weight reduction (mean, 1.7 kg). The mean blood pressure decreased in both groups, with greater reductions in the placebo group than in the sibutramine group (mean difference, 1.2/1.4 mm Hg). The risk of a primary outcome event was 11.4% in the sibutramine group as compared with 10.0% in the placebo group (hazard ratio, 1.16; 95% confidence interval [CI], 1.03 to 1.31; P=0.02). The rates of nonfatal myocardial infarction and nonfatal stroke were 4.1% and 2.6% in the sibutramine group and 3.2% and 1.9% in the placebo group, respectively (hazard ratio for nonfatal myocardial infarction, 1.28; 95% CI, 1.04 to 1.57; P=0.02; hazard ratio for nonfatal stroke, 1.36; 95% CI, 1.04 to 1.77; P=0.03). The rates of cardiovascular death and death from any cause were not increased. Conclusions Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk of nonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause. (Funded by Abbott; ClinicalTrials.gov number, NCT00234832.)

Published
2010

20. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study

Author

Thevenon, J, primary, Bourredjem, A, additional, Faivre, L, additional, Cardot-Bauters, C, additional, Calender, A, additional, Le Bras, M, additional, Giraud, S, additional, Niccoli, P, additional, Odou, M F, additional, Borson-Chazot, F, additional, Barlier, A, additional, Lombard-Bohas, C, additional, Clauser, E, additional, Tabarin, A, additional, Pasmant, E, additional, Chabre, O, additional, Castermans, E, additional, Ruszniewski, P, additional, Bertherat, J, additional, Delemer, B, additional, Christin-Maitre, S, additional, Beckers, A, additional, Guilhem, I, additional, Rohmer, V, additional, Goichot, B, additional, Caron, P, additional, Baudin, E, additional, Chanson, P, additional, Groussin, L, additional, Du Boullay, H, additional, Weryha, G, additional, Lecomte, P, additional, Schillo, F, additional, Bihan, H, additional, Archambeaud, F, additional, Kerlan, V, additional, Bourcigaux, N, additional, Kuhn, J M, additional, Vergès, B, additional, Rodier, M, additional, Renard, M, additional, Sadoul, J L, additional, Binquet, C, additional, and Goudet, P, additional

Published
2015
Full Text
View/download PDF

21. Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study

Author

Bordier, L., primary, Buysschaert, M., additional, Bauduceau, B., additional, Doucet, J., additional, Verny, C., additional, Lassmann Vague, V., additional, Le Floch, J.P., additional, Bauduceau, B, additional, Blicklé, J-F, additional, Bourdel-Marchasson, I, additional, Constans, T, additional, Doucet, J, additional, Fagot-Campagna, A, additional, Kaloustian, E, additional, Lassmann-Vague, V, additional, Lecomte, P, additional, Tessier, D, additional, Verny, C, additional, Vischer, U, additional, Affres, H, additional, Alix, M, additional, Archambeaud, F, additional, Barrou, Z, additional, Beau, P, additional, Beltran, S, additional, Benoit, C, additional, Beressi, J-P, additional, Bernachon, F, additional, Berne, C, additional, Berrut, G, additional, Blaimont, A, additional, Blickle, J-F, additional, Boda-Buccino, M, additional, Bohatier, J, additional, Böhme, P, additional, Bordier, L, additional, Bouchou, K, additional, Bouillet, B, additional, Bouilloud, F, additional, Bouix, R, additional, Boulanger, E, additional, Bourgon, C, additional, Bourrinet, E, additional, Brocker, P, additional, Bruckert, I, additional, Capet, C, additional, Carette, C, additional, Cariou, B, additional, Carreau, A, additional, Vaurie, C Chaillou, additional, Chamouni, S, additional, Ciangura, C, additional, Collet-Gaudillat, C, additional, Combes-Moukhovsky, M-E, additional, Cordonnier, M, additional, Cuperlier, A, additional, Dambre, D, additional, D'Avigneau, J, additional, De Botton, P, additional, Degros, V, additional, Delamarre-Damier, F, additional, Denat, S, additional, Desbiez, F, additional, Deumier, B, additional, Dorey, F, additional, Dresco, E, additional, Drutel, A, additional, De Saint Germain, E Du Rosel, additional, Dubois-Laforgue, D, additional, Duly-Bouhanick, B, additional, Dupuy, O, additional, Dusselier, L, additional, Faucher-Kareche, S, additional, Fendri, S, additional, Fontaine, P, additional, Galinat, S, additional, Gentric, A, additional, Gin, H, additional, Glaise, F, additional, Godeau, T, additional, Gonzales, B, additional, Got, I, additional, Guerci, B, additional, Guillausseau, P-J, additional, Hadjadj, S, additional, Hadjali, Y, additional, Halbron, M, additional, Halimi, S, additional, Halter, C, additional, Hanaire, H, additional, Hardy, V, additional, Hartemann-Heurtier, A, additional, Haulot, J-P, additional, Hequet, F, additional, Issa-Sayegh, M, additional, Jan, P, additional, Jeandidier, N, additional, Joseph-Henri, H, additional, Julier, I, additional, Kerlan, V, additional, Kharitonnoff, T, additional, Ladsous, M, additional, Lahaxe, L, additional, Lamaraud, M-P, additional, Lassenne, E, additional, Lecerf, J-M, additional, Leroux, I, additional, Lesven, S, additional, Levy, M, additional, Lopez, S, additional, Makiza, F, additional, Manckoundia, P, additional, Pomeau, C Marquis, additional, Mayaudon, H, additional, Micheli, S, additional, Mira, R, additional, Monnier, F, additional, Mosnier-Pudar, H, additional, Neri, N, additional, Normand, I, additional, Paccalin, M, additional, Pagu, C, additional, Paris, D, additional, Penfornis, A, additional, Perie, J-L, additional, Petit, J-M, additional, Petit-Aubert, G, additional, Pichot-Duclos, B, additional, Pivois, L, additional, Popelier, M, additional, Poulingue, G, additional, Priner, M, additional, Quipourt, V, additional, Rasamisoa, M, additional, Richard, J-L, additional, Rigalleau, V, additional, Roudat, N, additional, Sanz, C, additional, Serot, J-M, additional, Sifi, D, additional, Sirvain, S, additional, Slimani, A, additional, Sonnet, E, additional, Sosset, C, additional, Soualah, A, additional, Stroea, A, additional, Tauveron, I, additional, Timsit, J, additional, Tschudnowsky, M, additional, Vambergue, A, additional, Verier-Mine, O, additional, and Virally, M, additional

Published
2015
Full Text
View/download PDF

22. Description prospective des manifestations du complexe de Carney : première analyse du PHRC national EVA-Carney

Author

Espiard, S., primary, Cardot-Bauters, C., additional, Raverot, G., additional, Nunes, M.L., additional, Brucker-Davis, F., additional, Houang, M., additional, Archambeaud, F., additional, Lienhardt, A., additional, Lefebvre, H., additional, Chabre, O., additional, Tabarin, A., additional, Vantyghem, M.C., additional, and Bertherat, J., additional

Published
2015
Full Text
View/download PDF

25. The Poor Prognosis of Diabetic Patients with High Ankle-Brachial Index. Depends on the Presence of masked Peripheral Arterial Disease

Author

Aboyans, Victor, Tran, M.H., Salamagne, Claire, Archambeaud, F., Criqui, M. H., Laskar, Marc, Neuroépidémiologie Tropicale et Comparée (NETEC), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Université de Limoges (UNILIM), Service de Chirurgie Thoracique et Vasculaire - Médecine vasculaire [CHU Limoges], CHU Limoges, Equipe de Recherche Médicale Appliquée (ERMA), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Université de Limoges (UNILIM)-CHU Limoges, and Merigaud, Françoise

Subjects
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

ERMA; International audience

Published
2008

26. Familial isolated pituitary adenomas : clinical characterization and epidemiology J

Author

A.F., Daly, M.L., Jaffrain-Rea, Ciccarelli, E., Brue, Thierry, Ferolla, P., Emy, P., Colao, A., Menis E., De, Lecomte, P., Penfornis, F., Delemer, B., Bertherat, J., J.L., Wemeau, Herder W., De, Archambeaud, F., Stevenaert, A., Calender, A., Murat, François, Beckers, A., Interactions cellulaires neuroendocriniennes (ICN), Université de la Méditerranée - Aix-Marseille 2-Centre National de la Recherche Scientifique (CNRS), and Gautron, Conception

Published
2007

27. Familial isolated pituitary adenomas

Author

Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, E., Brue, Thierry, Ferolla, P., Emy, P., Colao, A., de Menis, E., Lecompte, P., Penfornis, F., Delemer, B., Bertherat, J., Wemeau, J.L., de Herder, W., Archambeaud, F., Stevenaert, A., Calender, A., Murat, François, Beckers, A., Gautron, Conception, Interactions cellulaires neuroendocriniennes (ICN), and Université de la Méditerranée - Aix-Marseille 2-Centre National de la Recherche Scientifique (CNRS)

Published
2006

28. Concerns over the consequences of regional disparities for elderly French type 2 diabetes patients in the Gerodiab study

Author

Le Floch, J.-P., primary, Doucet, J., additional, Bauduceau, B., additional, Verny, C., additional, Bauduceau, B, additional, Blicklé, J-F, additional, Bourdel-Marchasson, I, additional, Constans, T, additional, Doucet, J, additional, Fagot-Campagna, A, additional, Kaloustian, E, additional, Lassmann-Vague, V, additional, Lecomte, P, additional, Tessier, D, additional, Verny, C, additional, Vischer, U, additional, Affres, H, additional, Alix, M, additional, Archambeaud, F, additional, Barrou, Z, additional, Beau, P, additional, Beltran, S, additional, Benoit, C, additional, Beressi, J-P, additional, Bernachon, F, additional, Berne, C, additional, Berrut, G, additional, Blaimont, A, additional, Blickle, J-F, additional, Boda-Buccino, M, additional, Bohatier, J, additional, Böhme, P, additional, Bordier, L, additional, Bouchou, K, additional, Bouillet, B, additional, Bouilloud, F, additional, Bouix, R, additional, Boulanger, E, additional, Bourgon, C, additional, Bourrinet, E, additional, Brocker, P, additional, Bruckert, I, additional, Capet, C, additional, Carette, C, additional, Cariou, B, additional, Carreau, A, additional, Vaurie, C Chaillou, additional, Chamouni, S, additional, Ciangura, C, additional, Collet-Gaudillat, C, additional, Combes-Moukhovsky, M-E, additional, Cordonnier, M, additional, Cuperlier, A, additional, Dambre, D, additional, D'Avigneau, J, additional, De Botton, P, additional, Degros, V, additional, Delamarre-Damier, F, additional, Denat, S, additional, Desbiez, F, additional, Deumier, B, additional, Dorey, F, additional, Dresco, E, additional, Drutel, A, additional, De Saint Germain, E Du Rosel, additional, Dubois-Laforgue, D, additional, Duly-Bouhanick, B, additional, Dupuy, O, additional, Dusselier, L, additional, Faucher-Kareche, S, additional, Fendri, S, additional, Fontaine, P, additional, Galinat, S, additional, Gentric, A, additional, Gin, H, additional, Glaise, F, additional, Godeau, T, additional, Gonzales, B, additional, Got, I, additional, Guerci, B, additional, Guillausseau, P-J, additional, Hadjadj, S, additional, Hadjali, Y, additional, Halbron, M, additional, Halimi, S, additional, Halter, C, additional, Hanaire, H, additional, Hardy, V, additional, Hartemann-Heurtier, A, additional, Haulot, J-P, additional, Hequet, F, additional, Issa-Sayegh, M, additional, Jan, P, additional, Jeandidier, N, additional, Joseph-Henri, H, additional, Julier, I, additional, Kerlan, V, additional, Kharitonnoff, T, additional, Ladsous, M, additional, Lahaxe, L, additional, Lamaraud, M-P, additional, Lassenne, E, additional, Lecerf, J-M, additional, Leroux, I, additional, Lesven, S, additional, Levy, M, additional, Lopez, S, additional, Makiza, F, additional, Manckoundia, P, additional, Pomeau, C Marquis, additional, Mayaudon, H, additional, Micheli, S, additional, Mira, R, additional, Monnier, F, additional, Mosnier-Pudar, H, additional, Neri, N, additional, Normand, I, additional, Paccalin, M, additional, Pagu, C, additional, Paris, D, additional, Penfornis, A, additional, Perie, J-L, additional, Petit, J-M, additional, Petit-Aubert, G, additional, Pichot-Duclos, B, additional, Pivois, L, additional, Popelier, M, additional, Poulingue, G, additional, Priner, M, additional, Quipourt, V, additional, Rasamisoa, M, additional, Richard, J-L, additional, Rigalleau, V, additional, Roudat, N, additional, Sanz, C, additional, Serot, J-M, additional, Sifi, D, additional, Sirvain, S, additional, Slimani, A, additional, Sonnet, E, additional, Sosset, C, additional, Soualah, A, additional, Stroea, A, additional, Tauveron, I, additional, Timsit, J, additional, Tschudnowsky, M, additional, Vambergue, A, additional, Verier-Mine, O, additional, and Virally, M, additional

Published
2014
Full Text
View/download PDF

29. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients

Author

Lebrethon, M.C., Avallet, O., Reznik, Y., Archambeaud, F., Combes, J., Usdin, T.B., Narboni, G., Mahoudeau, J., Saez, J.M., Communications Cellulaires et Différenciation (CCD), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Recherche Agronomique (INRA), and ProdInra, Migration

Subjects
[SDV] Life Sciences [q-bio], GIP, SURRENALE, [SDV]Life Sciences [q-bio], SYNDROME DE CUSHING
Published
1998

30. Les mutations SOX10 responsables de l’association des syndromes de Kallmann et Waardenburg

Author

Pingault, V., primary, Bodereau, V., additional, Baral, V., additional, Marcos, S., additional, Watanabe, Y., additional, Chaoui, A., additional, Fouveaut, C., additional, Leroy, C., additional, Verier-Mine, O., additional, Francannet, C., additional, Dupin-Deguine, D., additional, Archambeaud, F., additional, Kurtz, F., additional, Young, J., additional, Bertherat, J., additional, Marlin, S., additional, Goossens, M., additional, Hardelin, J.P., additional, Dode, C., additional, and Bondurand, N., additional

Published
2013
Full Text
View/download PDF

33. Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort.

Author

Doucet, Jean A., Bauduceau, Bernard, Le Floch, Jean‐Pierre, Verny, Christiane, Blicklé, JF, Bourdel‐Marchasson, I, Constans, T, Fagot‐Campagna, A, Lassmann‐Vague, V, Vischer, U, Affres, H, Alix, M, Archambeaud, F, Barrou, Z, Beau, P, Beltran, S, Benoit, C, Beressi, J‐P, Bernachon, F, and Berne, C

Subjects
TYPE 2 diabetes, DIABETES in old age, INSULIN, PEOPLE with diabetes, PUBLIC health
Abstract

Prevalence of diabetes in the elderly increases, and half of the French diabetics are over the age of 75 years. The GERODIAB study is the first French multicentre, prospective, observational study designed to analyse over 5 years the influence of glycaemic control on morbidity-mortality in type 2 diabetics patients 70 years old and over. This study analysed the diabetic and geriatric factors associated with the treatment modalities, particularly insulin, at inclusion in the cohort. The cohort of 987 type 2 diabetics was divided into three groups according to the method of treatment. Slightly fewer than one-third of these patients (26.4%) were treated with insulin alone, 31% received insulin and oral antidiabetic drugs, and 42.7% oral antidiabetic drugs alone. The patients that received insulin alone were significantly older, had poorer glycaemic control ( Hb A1c = 7.9 ± 1.4, 7.8 ± 1.0 and 7.1 ± 1.2%, respectively; P < 0.001) and had greater alterations of glomerular filtration rate ( GFR). Hb A1c was below 6.5% in 15% of patients and 37.3% of patients had a GFR below 60 mL/min. The patients treated with insulin alone had significantly more hypoglycaemic episodes (respectively 53.3, 36.3 and 19.5%, P < 0.001), retinopathy, cardiovascular involvement and more specific geriatric complications, such as cognitive disorders (respectively 34.1, 31.4 and 23.6%, P = 0.006). In this specific population of elderly type 2 diabetic patients, diabetic and geriatric conditions significantly differed between the types of drug treatments. Considering low values of Hb A1c and GFR, some patients seemed overtreated and other patients received inappropriate drugs. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

34. Clinical characterization of familial isolated pituitary adenomas

Author

Daly, A.F. (Adrian), Jaffrain-Rea, M-L. (Marie-Lise), Ciccarelli, E. (Enrica), Valdes-Socin, H. (H.), Rohmer, V. (Vincent), Tamburrano, G. (Guido), Borson-Chazot, F. (Francoise), Estour, B. (Bruno), Brue, T. (Thierry), Ferolla, P. (Piero), Emy, P. (Philippe), Colao, A. (Annamaria), Menis, E. (Ernesto) de, Lecomte, P. (Pierre), Penfornis, A. (Alfred), Delemer, B. (B.), Bertherat, J. (Jerome), Wémeau, J.L., Herder, W.W. (Wouter) de, Archambeaud, F. (Françoise), Stevenaert, A. (A.), Calender, A. (Alain), Murat, A. (Arnaud), Cavagnini, F. (Francesco), Beckers, A. (Albert), Daly, A.F. (Adrian), Jaffrain-Rea, M-L. (Marie-Lise), Ciccarelli, E. (Enrica), Valdes-Socin, H. (H.), Rohmer, V. (Vincent), Tamburrano, G. (Guido), Borson-Chazot, F. (Francoise), Estour, B. (Bruno), Brue, T. (Thierry), Ferolla, P. (Piero), Emy, P. (Philippe), Colao, A. (Annamaria), Menis, E. (Ernesto) de, Lecomte, P. (Pierre), Penfornis, A. (Alfred), Delemer, B. (B.), Bertherat, J. (Jerome), Wémeau, J.L., Herder, W.W. (Wouter) de, Archambeaud, F. (Françoise), Stevenaert, A. (A.), Calender, A. (Alain), Murat, A. (Arnaud), Cavagnini, F. (Francesco), and Beckers, A. (Albert)

Abstract

Context: Familial pituitary adenomas occur rarely in the absence of multiple endocrine neoplasia type 1(MEN1)and Carney complex (CNC). Objective: Our objective was to characterize the clinical and genealogical features of non-MEN1/CNC familial isolated pituitary adenomas (FIPA). Design and Setting: We conducted a retrospective study of clinical and genealogical characteristics of FIPA cases and performed a comparison with a sporadic population at 22 university hospitals in Belgium, Italy, France, and The Netherlands. Results: Sixty-four FIPA families including 138 affected individuals were identified [55 prolactinomas, 47 somatotropinomas, 28 nonsecreting adenomas (NS), and eight ACTH-se

Published
2006
Full Text
View/download PDF

47. Une cardiopathie galopante

Author

Archambeaud, F., primary, Lopez, S., additional, Galinatb, S., additional, Drutel, A., additional, Teissier, M.-P., additional, and Cornu, E., additional

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results